Top

Published in:

Open Access 01-12-2019 | Aneurysm | Correction

Correction to: Case report and management approach in idiopathic pulmonary arteries aneurysm

Authors: Saleem Haj-Yahia, Mohammad Sbaih, Khalil Bali, Ahmad Darwazah, Wafiq Othman, Mahmoud Zaghari, Gianni Angelini, Massimo Caputo, Abdel-karim Barqawi

Published in: Journal of Cardiothoracic Surgery | Issue 1/2019

Excerpt

Correction to: J Cardiothorac Surg …

Haj-Yahia S, et al. Case report and management approach in idiopathic pulmonary arteries aneurysm. J Cardiothorac Surg. 2018;13:110. https://doi.org/10.1186/s13019-018-0791-9.CrossRef

Title: Correction to: Case report and management approach in idiopathic pulmonary arteries aneurysm
Authors: Saleem Haj-Yahia
Mohammad Sbaih
Khalil Bali
Ahmad Darwazah
Wafiq Othman
Mahmoud Zaghari
Gianni Angelini
Massimo Caputo
Abdel-karim Barqawi
Publication date: 01-12-2019
Publisher: BioMed Central
Keywords: Aneurysm
Aneurysm
Published in: Journal of Cardiothoracic Surgery / Issue 1/2019
Electronic ISSN: 1749-8090
DOI: https://doi.org/10.1186/s13019-018-0822-6

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Correction to: Case report and management approach in idiopathic pulmonary arteries aneurysm

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2019

SUPERIOR SVG: no touch saphenous harvesting to improve patency following coronary bypass grafting (a multi-Centre randomized control trial, NCT01047449)

How should we treat uncomplicated subacute type B aortic dissection in octogenarians?

3D printing and thoracoscopy assisted MIPO in treatment of long-range comminuted rib fractures, a case report

Extensive aortic surgery in acute aortic dissection type A on outcome – insights from 25 years single center experience

Total laparoscopic and thoracoscopic Ivor Lewis esophagectomy after neoadjuvant Chemoradiation with minimal overall and anastomotic complications

A novel endothelial damage inhibitor for the treatment of vascular conduits in coronary artery bypass grafting: protocol and rationale for the European, multicentre, prospective, observational DuraGraft registry